DGAP-CMS: Logwin AG: Announcement pursuant to Article 5 (1b) and (3) of Regulation (EU) No. 596/2014 and Art. 2 (2) and (3) of Commission Delegated Regulation (EU) No. 2016/1052
2021. július 12., hétfő, 12:58
Announcement pursuant to Article 5 (1b) and (3) of Regulation (EU) No. 596/2014 and Art. 2 (2) and (3) of Commission Delegated Regulation (EU) No. 2016/1052 Acquisition of treasury shares - 60. Interim Announcement In the period from 5 July 2021 through 9 July 2021, in total 59 shares were acquired as part of the Logwin AG share buyback program. The start of the share buyback program was announced on 17 March 2020 for 18 March 2020 pursuance of Article 5 (1) a) of Regulation (EU) No. 596/2014 and Article 2 (1) of the Commission Delegate Regulation (EU) No. 2016/1052. Shares were acquired as follows:
The total number of shares acquired so far in the period from 18 March 2020 through 9 July 2021 in the course of the share repurchase amounts to 4,507 shares. The share buyback was carried out by an independent bank of Logwin AG exclusively via the stock exchange in the electronic XETRA trading system of the Frankfurt Stock Exchange. Information on the individual transactions and on the daily trading volume referred to in Article 5 (1b), (3) of Regulation (EU) No. 596/2014 in connection with Article 2 (2) and (3) of Commission Delegate Regulation (EU) No. 2016/1052 are published on the internet at the following link: https://www.logwin-logistics.com/company/investors/share/share-buyback-program-2020.html
|
Language: | English |
Company: | Logwin AG |
an de Längten 5 | |
L-6776 Grevenmacher | |
Luxemburg | |
Internet: | www.logwin-logistics.com |
End of News | DGAP News Service |
1217805 12.07.2021
Közzétételek - archívum
-
» Laxxon Medical to Participate in the BIO CEO & Investor Conference
[2023.02.02. 20:15]
-
» PJSC Magnitogorsk Iron and Steel Works: MMK notifies on additional extension of consent solicitation process
[2022.06.30. 13:00]
-
» Evonik Industries and Laxxon Medical see future in 3D screen printed pharmaceuticals
[2022.03.08. 15:02]
-
» Evonik und Laxxon Medical sehen Zukunftsmarkt für 3D-Druck von Tabletten
[2022.03.08. 15:02]
-
» "Game Changing" Technology Enables QR Code Integration with 3D Screen Printing
[2022.02.16. 17:31]
-
» Laxxon Medical to Participate in the 24th Annual Needham Virtual Growth Conference
[2022.01.07. 16:40]
-
» EQS-News: Focus Financial Partners Announces the Launch of Beryllus Capital in a Leading-Edge Joint Venture with the Hinduja Group
[2021.03.22. 12:45]
-
» DGAP-Adhoc: TRATON SE: TRATON und Navistar einig über Fortsetzung der Gespräche
[2020.10.16. 18:43]
-
» DGAP-Adhoc: TRATON SE: TRATON and Navistar agreement in principle
[2020.10.16. 18:43]